Bitterroot Bio to Present Preclinical Research at American Heart Association Conference
PALO ALTO, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Bitterroot Bio, a biotechnology company focused on developing novel immunotherapies in cardiovascular disease, has been selected to present research at the upcoming
United States Lori Clerkin Craig Basson American Heart Association Bitterroot Bio Inc American Heart Association Scientific Sessions
Source: benzinga.com